Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and ILE in Aluminum Phosphide Toxicity
NCT05370729Unknown
- Sponsor
- Assiut University
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of acetylcysteine in aluminum phosphide poisoning (2 arms), sponsored by Assiut University. Primary endpoint: Echocardiography at 24 hours. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
aluminum phosphide poisoning
Beyond the preview
Go deeper on NCT05370729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05370729.